| A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors (NCT05396391) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2022-06-22 |
| A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors (NCT05229497) | Akeso | 2022-05-04 |
| Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors (NCT05223231) | Nanjing Leads Biolabs Co.,Ltd | 2022-04-19 |
| A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors (NCT05235542) | Akeso | 2022-03-12 |
| A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients (NCT05198817) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-02-22 |
| A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors (NCT05193721) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2022-02-10 |
| A Study of AK112 in Advanced Malignant Tumors (NCT05214482) | Akeso | 2022-01-22 |
| A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors (NCT05110807) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2022-01-05 |
| A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant Tumors (NCT05102006) | Nanjing Leads Biolabs Co.,Ltd | 2021-11-30 |
| Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors (NCT05082545) | Atridia Pty Ltd. | 2021-11-23 |
| Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors (NCT04980690) | SUNHO（China）BioPharmaceutical CO., Ltd. | 2021-08-31 |
| Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors (NCT04708210) | Innovent Biologics (Suzhou) Co. Ltd. | 2021-04-28 |
| A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors (NCT04128085) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-11-15 |
| Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo (NCT05354076) | Fudan University | 2000-03-01 |